Grant: Fellowship - PA: Biomedical / Clinical HIV/AIDS Research
Direct Payment
$150,000.00
Defining the role of T cell metabolism in HIV-induced chronic immune activation and immune dysfunction.
FY 2011-12
Summary
The molecular and cellular pathways that lead from HIV infection to AIDS are complex, multifactorial and not understood. However, a number of recent studies have identified several key immune features in HIV infected individuals that characterize the progression to AIDS. One such feature is the state of general chronic immune activation in HIV individuals, which is a better predictor of AIDS progression than viral load. We have yet to understand the underlying causes and maintenance of chronic immune activation that is often exasperated by immune dysfunction in HIV individuals. The depletion of CD4+ T cells and the expansion of non-functional CD8+ T cells confound the search for underlying factors. Since chronic immune activation is a key player in the pathogenesis of AIDS, therapeutic interventions to reduce it may positively impact the overall immune function in HIV individuals.
Altered metabolism in T cells in HIV individuals could be an underlying factor of chronic immune activation. Mammalian target of rapamycin (mTOR), a protein molecule, is a key regulator of metabolism that once activated directs T cell activation, differentiation and function. mTOR controls not only the positive signals to direct functions of T cells but also the negative signals to turn itself off when not required. Dysregulated mTOR has been implicated in cancer where normal growth is sacrificed for uncontrolled growth to the detriment of the organism and likewise loss of mTOR retards growth. The hypothesis of my project is that in HIV infection T cells fail to either turn off or tone down mTOR activities leading to chronic immune activation and immune dysfunction. To date, mTOR functions with metabolism have not been investigated in T cells from HIV. The goal of my project is to define the interplay between mTOR, metabolism and chronic immune activation, and with this knowledge therapeutic interventions could be developed to reduce chronic immune activation and immune dysfunction.
Department
Program
Fellowship - PA: Biomedical / Clinical HIV/AIDS Research
Recipient
Location
Pennsylvania, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
243129
Name
Rahman A. K. M. Nur-ur
Region
Pennsylvania
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Defining the role of T cell metabolism in HIV-induced chronic immune activation and immune dysfunction.
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Fellowship - PA: Biomedical / Clinical HIV/AIDS Research
Keyworddelim
Aids; Chronic Immune Activation; Hiv; Immune Dysregulation; Metabolic Phenotype; Mtor Signaling Pathway; Polychromatic Facs Analysis; Polychromatic Imaging Facs Analysis; T Cell Metabolism
Abstract
The molecular and cellular pathways that lead from HIV infection to AIDS are complex, multifactorial and not understood. However, a number of recent studies have identified several key immune features in HIV infected individuals that characterize the progression to AIDS. One such feature is the state of general chronic immune activation in HIV individuals, which is a better predictor of AIDS progression than viral load. We have yet to understand the underlying causes and maintenance of chronic immune activation that is often exasperated by immune dysfunction in HIV individuals. The depletion of CD4+ T cells and the expansion of non-functional CD8+ T cells confound the search for underlying factors. Since chronic immune activation is a key player in the pathogenesis of AIDS, therapeutic interventions to reduce it may positively impact the overall immune function in HIV individuals.
Altered metabolism in T cells in HIV individuals could be an underlying factor of chronic immune activation. Mammalian target of rapamycin (mTOR), a protein molecule, is a key regulator of metabolism that once activated directs T cell activation, differentiation and function. mTOR controls not only the positive signals to direct functions of T cells but also the negative signals to turn itself off when not required. Dysregulated mTOR has been implicated in cancer where normal growth is sacrificed for uncontrolled growth to the detriment of the organism and likewise loss of mTOR retards growth. The hypothesis of my project is that in HIV infection T cells fail to either turn off or tone down mTOR activities leading to chronic immune activation and immune dysfunction. To date, mTOR functions with metabolism have not been investigated in T cells from HIV. The goal of my project is to define the interplay between mTOR, metabolism and chronic immune activation, and with this knowledge therapeutic interventions could be developed to reduce chronic immune activation and immune dysfunction.
Competitiondate
201110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Rahman, A. K. M. Nur-ur
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~